Cowden syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*[[Pharmacological|Pharmacologic]] medical [[therapy]] is recommended among patients with [[cutaneous]] manifestations in [[cowden syndrome]] patients. | *[[Pharmacological|Pharmacologic]] medical [[therapy]] is recommended among patients with [[cutaneous]] manifestations in [[cowden syndrome]] patients. | ||
**Preferred regimen (1): [[Acitretin]] for [[cutaneous]] manifestations. | **Preferred regimen (1): [[Acitretin]] for [[cutaneous]] manifestations. | ||
**[[Acitretin]] should be discontinued once the recurrence of skin lesions are noted. | **[[Acitretin]] should be discontinued once the recurrence of skin [[Lesion|lesions]] are noted. | ||
*[[Screening]] for multiple [[cancers]] should be effectively done in the patients with [[cowden syndrome]]. | |||
Revision as of 12:50, 19 March 2019
|
Cowden syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cowden syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Cowden syndrome medical therapy |
|
Risk calculators and risk factors for Cowden syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Due to different phenotypes cowden syndrome is likely to be an underdiagnosed condition. Pharmacologic medical therapy is recommended among patients with cutaneous manifestations in cowden syndrome.
Medical Therapy
- Pharmacologic medical therapy is recommended among patients with cutaneous manifestations in cowden syndrome patients.
- Screening for multiple cancers should be effectively done in the patients with cowden syndrome.